XAIR Live signals | Maximize Profits with Getagraph.com

SELL 104352 min ago

@ $2.12

Issued: 12 Feb 2024 @ 15:17

Return: -39.60%

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 16:00):

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system...

Stats
Today's Volume	407 317
Average Volume	308 419
Market Cap	58.75M
EPS	$0 ( 2024-02-12 )
Next earnings date	( $-0.510 ) 2024-06-27
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.600
ATR14	$0.00800 (0.63%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-20	Lisi Steven A.	Buy	950 000	Stock Option (right to buy)
2024-03-20	Gaul Michael A.	Buy	350 000	Stock Option (right to buy)
2024-03-20	Lee Yoori	Buy	45 000	Stock Option (right to buy)
2024-03-20	Carey Robert	Buy	90 000	Stock Option (right to buy)
2024-03-20	Bentsur Ron	Buy	45 000	Stock Option (right to buy)

INSIDER POWER
97.62
Last 97 transactions
Buy: 8 447 739 \| Sell: 475 627

Volume Correlation

Long: 0.18 (neutral)

Short: 0.02 (neutral)

Signal:(52.484) Neutral

Beyond Air Inc Correlation

10 Most Positive Correlations
PAIC	0.905
TLGT	0.904
SPRT	0.883
SVOK	0.864
SVAC	0.863
RMRM	0.842
GOODM	0.821

10 Most Negative Correlations
NETE	-0.879
MMAC	-0.839
AMRB	-0.835
RAVN	-0.833
BOCH	-0.816

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beyond Air Inc Correlation - Currency/Commodity

-0.15
( neutral )

0.17
( neutral )

0.00
( neutral )

0.03
( neutral )

-0.61
( weak negative )

0.29
( neutral )

Beyond Air Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-555 000 (0.00 %)
EPS:	$-1.860

Q3	2024
Revenue:	$391 000
Gross Profit:	$-683 500 (-174.81 %)
EPS:	$-0.500

Q2	2024
Revenue:	$239 000
Gross Profit:	$-193 000 (-80.75 %)
EPS:	$-0.510

Q1	2024
Revenue:	$59 000.00
Gross Profit:	$-244 000 (-413.56 %)
EPS:	$-0.450

Financial Reports:

No articles found.

Beyond Air Inc

Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.